The groundbreaking approach of tirzepatide peptide represents a significant advance in the care of type 2 diabetes. Unlike existing drugs, tirzepatide affects dual pathways – the GLP-1 hormone and GIP – providing https://tirzepatidepeptide997870.estate-blog.com/40802084/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment